Impact of Endovascular Treatment on Peripheral Vascular Disease

Impact of Endovascular Treatment on Peripheral Vascular Disease - Endovascular Treatment and Peripheral Vascular Disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047534

Enrollment

Registered

2022-04-20

Start date

2016-04-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral vascular disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with peripheral vascular disease above 20 years old

Exclusion criteria

Exclusion criteria: maintenance hemodialysis contrast medium allergy pregnant women or the women who may become pregnant and nursing pacemaker implantation

Design outcomes

Primary

Measure	Time frame
Relationships between thigh muscle mass, blood glucose, and apolipoproteins	—

Secondary

Measure	Time frame
Relationships between the changes in thigh muscle mass, blood glucose, and apolipoproteins	—

Countries

Japan

Contacts

Public ContactHidenori Komiyama

Nippon Medical School Chiba Hokusoh Hospital Cardiovascular center

h-komiyama0317@nms.ac.jp0476-99-1111

Outcome results